Perpetual Investment Management LTD Bio N Tech Se Transaction History
Perpetual Investment Management LTD
- $838 Million
- Q4 2022
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$840 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$442 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$418 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$376 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$198 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...